AndreaBozzo/ceres-open-data-index huggingface dataset:
Patent AT-E400323-T1: [Translated] DYEING COMPOSITION CONTAINING CERTAIN POLYCATIONIC DIRECT DYES, METHOD, USE AND KIT

Composition for dyeing human keratinic fibers comprises a conjugate (I) consisting of two azo, methine, azomethine, phenothiazine, triarylmethane, xanthene, phenanthridine or phthalocyanine dye molecules linked by a hydrocarbon group containing at least one nitrogen atom and having at least two cationic charges.  Composition for dyeing human keratinic fibers comprises a conjugate of formula (I).  D-Z-D (I)  D  =  an azo, methine, azomethine, phenothiazine, triarylmethane, xanthene, phenanthridine or phthalocyanine dye; and Z  =  a 1-20C hydrocarbon group containing at least one nitrogen atom and having at least two cationic charges. Independent claims are also included for:  (1) direct dyeing of human keratinic fibers by applying at least one of the compositions;  (2) oxidation dyeing of human keratinic fibers by applying at least one of the compositions, which also contains at least one developer and optionally at least one coupler, in the presence of an oxidizing agent;  (3) kit comprising the composition in one compartment and an oxidizing composition in another compartment.
Compound 527547: 2,5-Dimethyl-1-propyl-1H-pyrrole

Chemical compound data from PubChem database. IUPAC Name: 2,5-dimethyl-1-propylpyrrole. Molecular Formula: C9H15N. Molecular Weight: 137.22. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Supporting Evidence-Based Home Visitation Programs to Prevent Child Abuse and Neglect Project: Child and Family Tennessee

Location:

East Tennessee, which is composed of 16 diverse counties.

Home Visiting Program Selected:

Nurse Family Partnership; Family Connections

Home Visiting Target Population:

At-risk, low income females who are pregnant; first-time mothers will be given priority

Project Overview:
Child and Family Tennessee (CFT) aims to reduce child maltreatment through Project Babies, an intensive home visitation service program targeted for at-risk pregnant women and young mothers in a 16 county area of east Tennessee. The project will replicate two family intervention models – Nurse Family Partnership (NFP) and with some families, the Family Connections model. The overall goals of the project include improving the health and living situations of participants, promoting the widespread adoption and sustainability of home visitation services; and evaluating the effectiveness of these interventions for specific populations. The proposed evaluation will include a process analysis, a quasi-experimental evaluation, and an economic cost study. Additionally, the grantee will be working with fourteen selected State and local partners to ensure the sustainability of the project.

Metadata-only record linking to the original dataset. Open original dataset below.
Patent AT-E400246-T1: [Translated] A COMPOSITION FOR OXIDATION COLORING OF KERATIN FIBERS CONTAINING A THICKENING POLYMER WITH AN AMINO PLASTETHER MAIN CHAIN

The invention relates to an oxidation dye composition for keratinic fibers, especially for human keratinic fibers such as hair, containing at least one oxidation dye and a thickening polymer with a plastic ether skeleton, in a medium which is suitable for dyeing. The invention also relates to the dyeing method and devices for using the inventive composition.
Low frequency of

In order to explore the possible role of E-cadherin in familial cancer, 19 familial breast cancer patients, whose tumours demonstrated loss of heterozygosity (LOH) at the E-cadherin locus, were screened for germline mutations. No pathogenic germline alterations were detected in these individuals. However, a somatic mutation was found (49-2A→C) in one of the tumours. This tumour showed a pattern of both ductal and lobular histology. Another 10 families with cases of breast, gastric and colon cancer were also screened for germline mutations, and no mutations were found. A missense mutation in exon 12 of E-cadherin (1774G→A; Ala592Thr) was previously found in one family with diffuse gastric cancer, and colon and breast cancer. An allelic association study was performed to determine whether the Ala592Thr alteration predisposes to breast cancer. In total, we studied 484 familial breast cancer patients, 614 sporadic breast cancer patients and 497 control individuals. The frequencies of this alteration were similar in these groups. However, a correlation between the Ala592Thr alteration and ductal comedo-type tumour was seen. These results, together with previously reported studies, indicate that germline mutations and, more commonly, somatic mutations in E-cadherin may have an influence on the behaviour of the tumours, rather than predispose to breast cancer.
Compound 525644: N,N-Dimethyl-N'-pentyl-p-methoxybenzamidine

Chemical compound data from PubChem database. IUPAC Name: 4-methoxy-N,N-dimethyl-N'-pentylbenzenecarboximidamide. Molecular Formula: C15H24N2O. Molecular Weight: 248.36. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 530528: 5-Chlorovaleric acid, tetradecyl ester

Chemical compound data from PubChem database. IUPAC Name: tetradecyl 5-chloropentanoate. Molecular Formula: C19H37ClO2. Molecular Weight: 332.9. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Delta-Notch signaling and lateral inhibition in zebrafish spinal cord development

Background
          Vertebrate neural development requires precise coordination of cell proliferation and cell specification to guide orderly transition of mitotically active precursor cells into different types of post-mitotic neurons and glia. Lateral inhibition, mediated by the Delta-Notch signaling pathway, may provide a mechanism to regulate proliferation and specification in the vertebrate nervous system. We examined delta and notch gene expression in zebrafish embryos and tested the role of lateral inhibition in spinal cord patterning by ablating cells and genetically disrupting Delta-Notch signaling.
        
        
          Results
          Zebrafish embryos express multiple delta and notch genes throughout the developing nervous system. All or most proliferative precursors appeared to express notch genes whereas subsets of precursors and post-mitotic neurons expressed delta genes. When we ablated identified primary motor neurons soon after they were born, they were replaced, indicating that specified neurons laterally inhibit neighboring precursors. Mutation of a delta gene caused precursor cells of the trunk neural tube to cease dividing prematurely and develop as neurons. Additionally, mutant embryos had excess early specified neurons, with fates appropriate for their normal positions within the neural tube, and a concomitant deficit of late specified cells.
        
        
          Conclusions
          Our results are consistent with the idea that zebrafish Delta proteins, expressed by newly specified neurons, promote Notch activity in neighboring precursors. This signaling is required to maintain a proliferative precursor population and generate late-born neurons and glia. Thus, Delta-Notch signaling may diversify vertebrate neural cell fates by coordinating cell cycle control and cell specification.
4.11a Facilities offering special programs or groups for specific client types, by facility operation and primary focus of facility: 2011. Number

This is a National Survey of Substance Abuse Treatment Services (N-SSATS) data table showing facilities offering special programs or groups for specific client types, by facility operation and primary focus of facility in 2011. N-SSATS is designed to collect data on the location, characteristics, and use of alcohol and drug abuse treatment facilities and services throughout the 50 States, the District of Columbia, and other U.S. jurisdictions.
Intensive care transfers

The demand for intensive care has increased relentlessly over the past 30 years. It is now regarded as a necessity rather than a luxury. The provision of intensive care has lagged behind that demand. Thus, patients who are judged to need intensive care when a bed is unavailable are increasingly transferred to another hospital for such care. The present commentary discusses intensive care transfers and describes a website being trialled in the UK that helps with locating available intensive care beds.
State Health IT Privacy and Consent Laws and Policies

This data was collected by the Office of the National Coordinator for Health IT in coordination with Clinovations and the George Washington University Milken Institute of Public Health. ONC and its partners collected the data through research of state government and health information organization websites. The dataset provides policy and law details for four distinct policies or laws, and, where available, hyperlinks to official state records or websites. These four policies or laws are: 1) State Health Information Exchange (HIE) Consent Policies; 2) State-Sponsored HIE Consent Policies; 3) State Laws Requiring Authorization to Disclose Mental Health Information for Treatment, Payment, and Health Care Operations (TPO); and 4) State Laws that Apply a Minimum Necessary Standard to Treatment Disclosures of Mental Health Information.
U.S. State and Territorial Stay-At-Home Orders: March 15, 2020 – May 31, 2021 by County by Day

State and territorial executive orders, administrative orders, resolutions, and proclamations are collected from government websites and cataloged and coded using Microsoft Excel by one coder with one or more additional coders conducting quality assurance.

Data were collected to determine when individuals in states and territories were subject to executive orders, administrative orders, resolutions, and proclamations for COVID-19 that require or recommend people stay in their homes. Data consists exclusively of state and territorial orders, many of which apply to specific counties within their respective state or territory; therefore, data is broken down to the county level.

These data are derived from the publicly available state and territorial executive orders, administrative orders, resolutions, and proclamations (“orders”) for COVID-19 that expressly require or recommend individuals stay at home found by the CDC, COVID-19 Community Intervention and At-Risk Task Force, Monitoring and Evaluation Team & CDC, Center for State, Tribal, Local, and Territorial Support, Public Health Law Program from March 15, 2020 through May 31, 2021. These data will be updated as new orders are collected. Any orders not available through publicly accessible websites are not included in these data. Only official copies of the documents or, where official copies were unavailable, official press releases from government websites describing requirements were coded; news media reports on restrictions were excluded. Recommendations not included in an order are not included in these data. These data do not include mandatory business closures, curfews, or limitations on public or private gatherings. These data do not necessarily represent an official position of the Centers for Disease Control and Prevention.
Table 12. Alcohol Use and Binge Alcohol Use in the Past Month among Persons Aged 12 to 20, by State: Percentages, Annual Averages Based on 2010 and 2011 NSDUHs

This report presents State estimates for measures of past month alcohol use and binge alcohol use among those aged 12 to 20 based on the combined 2010 and 2011 National Surveys on Drug Use and Health (NSDUHs).
Phoenix: Drug-Related Emergency Department Visits, 2004-2011 - All Visits

Excel file with estimates, rates, relative standard errors, trends and confidence intervals for all drug-related emergency department (ED) visits in the Phoenix metropolitan area, covering 2004-2011. File includes all drug-related ED visits that are reportable to DAWN without regard for the reason for the visit or the specific drugs involved. It includes visits involving all forms of drug misuse or abuse plus visits resulting from adverse reaction, accidental ingestion, suicide attempts, and visits where patients were seeking detoxification services. These estimates are useful for looking at overall levels of drug involvement in ED visits.File includes data for over 500 drugs, including illicit drugs, prescription and over-the-counter medications, dietary supplements, inhalants and alcohol.  Includes total visits, gender, age group, race/ethnicity, outcome of visit, drug combinations, number of drugs involved in visit, drug frequency, and drugs confirmed by toxicology.Additional detail is provided for illicit drugs, psychotherapeutic drugs, central nervous system (CNS) drugs, respiratory drugs and cardiovascular drugs.
Patent AT-E401388-T1: [Translated] PROTOMICROEMULSION, CLEANING DEVICE CONTAINING SAME AND USE THEREOF

An ionic surfactant-based protomicroemulsion or microemulsion composition contains, by weight, at least about 20% of an ionic surfactant system, from about 0.1% to about 50% of a low water-soluble compound, and from about 5% to about 79% of a solvent, and is substantially free of low water-soluble oils. The protomicroemulsion forms a microemulsion when diluted from about 10% to about 99% with water.
Patent AT-E40144-T1: [Translated] RUBBER PRODUCTS AND VULCANIZATION SYSTEMS.

A novel mixture comprises a dihydrocarbyl xanthogen polysulphide and a xanthate selected from metal hydrocarbylxanthates and dihydrocarbylxanthates. Such a mixture can be used to cure a vulcanisable rubber composition containing less than 0.4 parts by weight of nitrosatable materials per 100 parts by weight rubber; the use of toxic conventional nitrogen-containing accelerators such as amines can be avoided.
HHS System of Records Notices (SORNs) Metadata Inventory

The U.S. Department of Health and Human Services (HHS) publishes the HHS System of Records Notices (SORNs) Metadata Inventory to provide machine-readable access to over 200 publicly available SORNs that HHS has published in the Federal Register pursuant to the Privacy Act (5 U.S.C. § 552a). These notices inform the public about records HHS maintains on individuals which HHS retrieves by personal identifier. The inventory is available via open API and downloadable Excel or CSV formats.
National Directory of Drug and Alcohol Abuse Treatment Facilities

TheNational Directory of Drug and Alcohol Abuse Treatment Facilities - 2021is a listing of federal, state, and local government facilities and private facilities that provide substance abuse treatment services. It includes treatment facilities that (1) are licensed, certified, or otherwise approved for inclusion in the Directory by their State Substance Abuse Agencies, and (2) responded to the 2020 National Survey of Substance Abuse Treatment Services (N-SSATS). The information about each facility that appears in this Directory was provided by that facility in response to the 2020 N-SSATS. N-SSATS is conducted annually by the Substance Abuse and Mental Health Services Administration (SAMHSA).The Directory is ordered alphabetically by state, by city within each state, and by facility name within each city. Each facility listing includes codes that represent the services offered and other features of the facility, including codes that indicate services for hearing impaired and non-English-speaking clients. Codes are defined in a key shown on pages v-x. Because the services offered by a particular facility may change over time, it is always a good idea to verify the information in this Directory when contacting a facility.
Patent AT-E399713-T1: [Translated] DEVICE FOR SEALING BOWL OR CUP SHAPED CONTAINERS

The machine for sealing blister packs or tubs of dairy product has a heated sealing head (5) mounted on bolts (8) which are biased towards the head by springs (9) with a bearing plate (7) fitted over them. A tilting adjuster plate (6) allows the distance between the bearing plate and sealing head to be varied.
Patent AT-E401082-T1: [Translated] MEDICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF CEREBROVASCULAR DISORDERS

A pharmaceutical composition comprising at least one of components (a) and at least one of components (b) shown in below:  (a) a compound represented by the general formula (I) <CHEM> (wherein Rl represents a hydrogen atom or a hydroxyl group) or an acid addition salt or hydrate thereof; and (b) an ameliorant of cerebral circulation, a vasodilator, a cerebral protecting drug, an brain metabolic stimulants, an an ticoagulant, an antiplatelet drug, a thrombolytic drug, an ameli rant of psychiatric symptom, a antihypertensive drug, an antiang inal drug, a diuretic, a cardiotonic, an antiarrhythmic drug, an antihyperlipidemic drug, an immunosuppressant , or a pharmaceut ically acceptable salt (except the components shown in (a)). It is useful as a preventive or remedy for cerebrovascular disorde rs and cardiac diseases.
Compound 529301: (3-Chloromethyloxetan-3-yl)methanol

Chemical compound data from PubChem database. IUPAC Name: [3-(chloromethyl)oxetan-3-yl]methanol. Molecular Formula: C5H9ClO2. Molecular Weight: 136.58. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 528247: 2-Methyl-5-vinylthiophene

Chemical compound data from PubChem database. IUPAC Name: 2-ethenyl-5-methylthiophene. Molecular Formula: C7H8S. Molecular Weight: 124.21. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 525321: 5-Methyl-2H-pyrazole-3-carboxylic acid, 1-methyl-2-phenylhydrazide

Chemical compound data from PubChem database. IUPAC Name: N,5-dimethyl-N'-phenyl-1H-pyrazole-3-carbohydrazide. Molecular Formula: C12H14N4O. Molecular Weight: 230.27. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Provider Network Data: 2021 Quarter 2

This Provider Network Data contains information on individual and institutional providers participating in health plan networks from April through June 2021. Plan network data is collected from Medicaid, Commercial, and Exchange plans on a quarterly basis by the Department of Health, including managed care plans, as well as PPO/EPO plans.

For more information, please visit: <a href=https://pndslookup.health.ny.gov>https://pndslookup.health.ny.gov</a>
Compound 529537: 2-Hex-5-enyl-3-octa-2,5-dienyloxirane

Chemical compound data from PubChem database. IUPAC Name: 2-hex-5-enyl-3-octa-2,5-dienyloxirane. Molecular Formula: C16H26O. Molecular Weight: 234.38. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Use characteristics, visitor preferences, and conflict between horse users and hikers in the Charles C. Deam Wilderness Area: 1990-1991 visitor survey data

The Charles C. Deam Wilderness area is located on the Hoosier National Forest in Indiana. There has been historic use of this area by both hikers and horse riders, however there was substantial concern about the interaction and conflict between these two groups in this wilderness area. Between the summers of 1990 and 1991 a mailback questionnaire was sent to people visiting the Charles C. Deam Wilderness are for recreational purposes to investigate visitor use characterstics and preferences about their wilderness experience. Data include visitor activity, visitor characteristics, interaction with other groups, opinions regarding management policies, current wilderness conditions, preferred wilderness conditions, items influencing visitor quality, as well as user perception of similarities and differences between hikers and horse users.
Compound 530675: Phenylacetic acid, 2,7-dimethyloct-7-en-5-yn-4-yl ester

Chemical compound data from PubChem database. IUPAC Name: 2,7-dimethyloct-7-en-5-yn-4-yl 2-phenylacetate. Molecular Formula: C18H22O2. Molecular Weight: 270.4. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E400612-T1: [Translated] MOLDING COMPOUND CONTAINING POLYOXYMETHYLENE AND ZEOLITE

Molding material (A) comprises 10-99.999 (preferably 0.001-10) wt.% of at least a polyoxymethylene (a1) and at least one zeolitic material (b1) with a pore diameter of 0.3-0.5 nm, which is determined according to DIN 66134 and DIN 66135 standards, where the particle size of (b1) is 3-7 mu m in accordance to ISO 13320. An independent claim is also include for the preparation of (A).
Compound 525499: 5-Thia-1-heptanethiol

Chemical compound data from PubChem database. IUPAC Name: 4-ethylsulfanylbutane-1-thiol. Molecular Formula: C6H14S2. Molecular Weight: 150.3. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 525901: N,N-Dimethyl-N'-decyl-pivalamidine

Chemical compound data from PubChem database. IUPAC Name: N'-decyl-N,N,2,2-tetramethylpropanimidamide. Molecular Formula: C17H36N2. Molecular Weight: 268.5. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 525583: N,N-Dimethyl-N'-(3-nitrophenyl)-p-chlorobenzamidine

Chemical compound data from PubChem database. IUPAC Name: 4-chloro-N,N-dimethyl-N'-(3-nitrophenyl)benzenecarboximidamide. Molecular Formula: C15H14ClN3O2. Molecular Weight: 303.74. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 526635: [4-Methoxy-2-(methoxymethyl)oxolan-3-yl] acetate

Chemical compound data from PubChem database. IUPAC Name: [4-methoxy-2-(methoxymethyl)oxolan-3-yl] acetate. Molecular Formula: C9H16O5. Molecular Weight: 204.22. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Activation of synovial fibroblasts in rheumatoid arthritis: lack of
		  expression of the tumour suppressor PTEN at sites of invasive growth and
		  destruction

In the present study, we searched for mutant PTEN
			 transcripts in aggressive rheumatoid arthritis synovial fibroblasts (RA-SF) and
			 studied the expression of PTEN in RA. By automated sequencing, no evidence for
			 the presence of mutant PTEN transcripts was found. However, in
			 situ hybridization on RA synovium revealed a distinct expression pattern
			 of PTEN, with negligible staining in the lining layer but abundant expression
			 in the sublining. Normal synovial tissue exhibited homogeneous staining for
			 PTEN. In cultured RA-SF, only 40% expressed PTEN. Co-implantation of RA-SF and
			 normal human cartilage into severe combined immunodeficiency (SCID) mice showed
			 only limited expression of PTEN, with no staining in those cells
			 aggressively invading the cartilage. Although PTEN is not genetically altered
			 in RA, these findings suggest that a lack of PTEN expression may constitute a
			 characteristic feature of activated RA-SF in the lining, and may thereby
			 contribute to the invasive behaviour of RA-SF by maintaining their aggressive
			 phenotype at sites of cartilage destruction.